NCT01349426

Brief Summary

Surgical staplers have become standard for ligation, division, resection, anastomosis and closure in many surgical procedures. Staplers are utilized in thoracic surgery routinely for pulmonary parenchymal resection and closure, ligation of vessels and bronchi. In addition, closure of incomplete fissure/s is a frequent need in pulmonary surgery. Although generally safe and efficacious, staplers and staple loads are expensive, and can result in micro air leaks. The LigaSure Vessel Sealing System presents as a potentially faster and less expensive alternative to staplers. The LigaSure Vessel sealing system utilizes a combination of heat generated via bi-polar radiofrequency energy and precise jaw pressure to denature the collagen and elastin in tissue and blood vessels. The newly released Force Triad Generator and the Impact, a 10 mm jaw sealing device (Ligasure system, COVIDIEN Society) may offer improved performance in terms of tissue sticking due to an improved sealing algorithm, and to the jaw configuration of the Impact. The study main objective is to compare the quality of parenchymal pneumostasis after fissure closure achieved with staplers vs that achieved with LigaSure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Sep 2010

Typical duration for phase_3

Geographic Reach
1 country

10 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 6, 2011

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

July 28, 2015

Status Verified

July 1, 2015

Enrollment Period

4.4 years

First QC Date

May 4, 2011

Last Update Submit

July 27, 2015

Conditions

Keywords

Lung resectionParenchymal pneumostasis, haemostasisFissure closureAutomatic staplers,LigaSure, Force Triad GeneratorBipolar fusionProcedure cost

Outcome Measures

Primary Outcomes (1)

  • Rates of post-operative air leak between the two techniques

    Day 1

Secondary Outcomes (2)

  • Compare the number of lung stitches between LigaSure device and standard staplers

    Day 1

  • Evaluate the cost of LigaSure vs standard staplers in similar procedures including the cost of each instrument and the staple loads fired.

    Day 1

Study Arms (2)

LigaSure

EXPERIMENTAL

* Arm 1 * Patients undergoing lung surgery

Device: LigaSure Force Triad Vessel Sealing System

Automatic Staplers

ACTIVE COMPARATOR

* Arm 2 * Patients undergoing lung surgery

Device: LigaSure Force Triad Vessel Sealing System

Interventions

Quality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers

Also known as: Automatic Staplers TA30P, TA55, Endo GIA II MULTIFIRE
Automatic StaplersLigaSure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients older than 18 years
  • Patients scheduled for thoracotomy, lobectomy or bilobectomy
  • Patients must give informed consent

You may not qualify if:

  • Patient is unwilling or unable to provide informed consent
  • Patients who can not tolerate thoracotomy
  • Patients who require extensive dissection to release adhesions which may result in air leak and/or bleeding unrelated to the quality of the parenchymal seal achieved by the devices in question
  • Patients with no parenchymal bridge between lobes; 100% complete fissure.
  • Patients with complete incomplete fissure with a thickness \> 1.5 cm measure intraoperatively

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

CHU Lyon-Department of Thoracic Surgery, Cardiovascular and Chest Hospital

Bron, France

Location

CHU Clermont Ferrand - Service of Thoracic Surgery

Clermont-Ferrand, France

Location

CHU Grenoble - Department of Vascular and Thoracic Surgery

Grenoble, France

Location

CHU Lille - Service of Thoracic Surgery

Lille, France

Location

Hospital Dupuytren - Department of Thoracic and CardioVascular Surgery

Limoges, France

Location

CHU Marseille - Department of Thoracic Surgery

Marseille, France

Location

CHU Nice - Pasteur Hospital - Department of Thoracic Surgery

Nice, France

Location

Chu Saint-Etienne

Saint-Etienne, 42100, France

Location

CHU Strasbourg - Service of Thoracic Surgery

Strasbourg, France

Location

Department of Thoracic Surgery, Hospital Larrey, CHU Toulouse

Toulouse, France

Location

Study Officials

  • TIFFET Olivier, MD

    CHU Sainte-Etienne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2011

First Posted

May 6, 2011

Study Start

September 1, 2010

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

July 28, 2015

Record last verified: 2015-07

Locations